CohBar Granted U.S. Patent Covering CB4211 Compositions and Use for Treating Nonalcoholic Steatohepatitis (NASH)
MENLO PARK, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical
patent
Lysulin secures 5th patent for diabetes management supplement
Lysulin, Inc. recently announced they have secured patent approval for their flagship product Lysulin, a